share_log
Reuters ·  Apr 30 08:01
Sutro Biopharma Inc: Planned 50 Patients in Dose-Optimization (Part 1) of RefrΑMe-O1 Have Been Enrolled and Are in Follow up
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment